Design of Vaccine Candidate Based on Ebola Virus Epitop With In Silico Approach
Abstract
ABSTRACT
The World Health Organization (WHO) recorded as many as 2,299 cases of death with a case percentage of 66% during 2018 to 2020 in the Democratic Republic of the Congo due to the Ebola virus. Ebola virus is a member of the Filoviridae family. One of the viro cores consists of glycoprotein (GP). Messenger RNA (mRNA) generates long GP chains for the attachment protein (GP 1) and the fusion protein (GP 2). Epitope-based vaccines are a promising approach because epitopes represent immunogenic regions that elicit immunity specifically. Epitope prediction was performed based on the GP EBOV sequence available in the Data Bank. The designed vaccine could be one of the candidates for the Ebola virus vaccine. The design of the virus with access to NCBI AAB81004 was carried out by testing such as B cell epitope, T cell, and their antigenicity using the VaxiJen v2.0 server and IEDB. The T cell epitope prediction results showed that 20 T cell epitopes interacted with the Major Histocompatibility Complex (MHC) with the highest score of 2.8069. B cell epitope by linear BepiPred assay had 77 candidate epitope peptides from sequence 401-477. Karplus and Schulz's flexibility predictions showed a predictive value of 1.119 with a threshold of 1.008, with the analyzed area having an antigenic tendency where the threshold area was yellow.
Keywords: Ebolavirus; Vaccine; Epitope B Cell; Epitope T Cell; In Silico
Full Text:
PDFReferences
Dash, R., Das, R., Junaid, M., Akash, M. F. C., Islam, A., & Hosen, S. M. Z. (2017). In silico-based vaccine design against Ebola virus glycoprotein. Advances and Applications in Bioinformatics and Chemistry, 10(1), 11–28. https://doi.org/10.2147/AABC.S115859
Moghadam, S. R. J., Omidi, N., Bayrami, S., Moghadam, S. J., & SeyedAlinaghi, S. A. (2015). Ebola viral disease: A review literature. Asian Pacific Journal of Tropical Biomedicine, 5(4), 260–267. https://doi.org/10.1016/S2221-1691(15)30341-5
Patronov, A., & Doytchinova, I. (2013). T-cell epitope vaccine design by immunoinformatics. Open Biology, 3(JAN). https://doi.org/10.1098/rsob.120139
Rajak, H., Jain, D. K., Singh, A., Sharma, A. K., & Dixit, A. (2015). Ebola virus disease: Past, present and future. Asian Pacific Journal of Tropical Biomedicine, 5(5), 337–343. https://doi.org/10.1016/S2221-1691(15)30365-8
Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017). Fundamentals and Methods for T- and B-Cell Epitope Prediction. Journal of Immunology Research. https://doi.org/10.1155/2017/2680160
Sanchez, A., Kiley, M. P., Holloway, B. P., McCormick, J. B., & Auperin, D. D. (1989). The nucleoprotein gene of ebola virus: Cloning, sequencing, and in vitro expression. Virology, 170(1), 81–91. https://doi.org/10.1016/0042-6822(89)90354-1
Sridhar, S. (2015). Clinical development of Ebola vaccines. Therapeutic Advances in Vaccines, 3(5–6), 125–138. https://doi.org/10.1177/2051013615611017
Zawilińska, B., & Kosz-Vnenchak, M. (2014). General introduction into the Ebola virus biology and disease. Folia Medica Cracoviensia, 54(3), 57–65.
DOI: http://dx.doi.org/10.20527/jstk.v16i1.12167
Article Metrics
Abstract view : 514 timesPDF - 404 times
Refbacks
Dear colleagues,
We are pleased to inform you that the result of our application for journal accreditation has been finalized through the Arjuna system. Based on the assessment result, Jurnal Ilmiah Berkala Sains dan Terapan Kimia has now been officially accredited by Ministry of Research, Technology, and Higher Education of Republic of Indonesia with a predicate of SINTA 3. The official letter of the accreditation result is available through this link.
We hope that this accreditation result will lead us to more publications with better quality.
Sincerely,
Editorial Team of JIB Sains dan Terapan Kimia.
Alamat Redaksi:
Jl. A. Yani, KM. 36,
PROGRAM STUDI KIMIA
Kampus Fakultas Matematika dan Pengetahuan Alam, Gedung I,
Universitas Lambung Mangkurat, Banjarbaru (73714)
This work is licensed under a Creative Commons Attribution 4.0 International License.